source
- Neion Bio secures $23M Series A to develop egg-based protein platform for biologicsNeion Bio announced it closed a $23 million Series A round that was oversubscribed. The funding will be used to advance its platform that leverages chicken eggs, extracting primordial germ cells f…
- Sensorion halts development of SENS-501 for OTOF-related hearing loss after strategic reviewSensorion announced it is ending the development of its SENS-501 candidate, which was aimed at treating OTOF-related hearing loss, following a strategic review of its pipeline. The biotech said it…